Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6469]

AACR 2025: Adding perioperative pembrolizumab to standard of care improves outcomes in patients with newly diagnosed head and neck cancer

AACR 2025: Adding perioperative pembrolizumab to standard of care improves outcomes in patients with newly...

AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated lung cancer

AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated...

Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies

Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies

Drug dismantles a metabolic barrier to anti-tumour immunity

Drug dismantles a metabolic barrier to anti-tumour immunity

Study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Researchers use nanoparticles to target glioblastoma in mice

Researchers use nanoparticles to target glioblastoma in mice

Researchers reveal personalised approach to brain cancer monitoring

Researchers reveal personalised approach to brain cancer monitoring

Wake-up call for dormant cancer

Wake-up call for dormant cancer

Drug targets identified for pancreatic cancer

Drug targets identified for pancreatic cancer

Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma

Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma

More from ecancer